No single discrete molecular target

The classification 'No single discrete molecular target' refers to therapeutic agents that do not exert their primary pharmacological effect by binding to a specific, identifiable molecular entity such as a receptor, enzyme, or ion channel (ChEMBL, 2024). Instead, these agents function through broad physicochemical mechanisms that alter the physiological environment. For example, antacids like aluminum hydroxide and magnesium hydroxide work by chemically neutralizing gastric hydrochloric acid, while osmotic agents like mannitol increase urine production or bowel movements by creating an osmotic gradient that draws water into the renal tubules or intestinal lumen (Goodman & Gilman, 2023). Other examples include surfactants like simethicone, which change the surface tension of gas bubbles, and adsorbents like activated charcoal, which physically trap toxins to prevent their absorption (StatPearls, 2023). Because these substances lack a specific molecular 'lock-and-key' interaction, they are generally not subject to target-site resistance, but they can pose challenges in terms of systemic electrolyte balance and non-selective effects. This category is essential for distinguishing non-specific chemical or physical therapies from the majority of modern, target-directed pharmacological interventions.

Other names

Non-specific mechanismNon-molecular targetPhysicochemical mechanism of actionNon-receptor mediated actionUnknown molecular target

Therapeutic effects are achieved through non-specific physical or chemical interactions—such as acid-base neutralization, osmotic pressure alteration, adsorption, or surface tension changes—rather than through specific binding to a protein or nucleic acid target.